期刊文献+

芳基苄砜类化合物的合成及其蛋白酪氨酸激酶抑制活性评价 被引量:2

Synthesis and protein tyrosine kinases inhibitory activity of aryl benzyl sulfones derivatives
下载PDF
导出
摘要 目的以Ex-Rad为先导化合物,设计合成具有蛋白酪氨酸激酶(PTK)抑制活性的芳基苄砜类化合物。方法以2-萘酚等为原料,合成中间体3a^3f,用过氧化氢在冰乙酸中将3a^3f氧化成目标化合物4a、4b、5a^5f。用酶联免疫吸附法(ELISA)测定PTK抑制活性,计算抑制率,筛选出具有抑制PTK活性的化合物。结果合成含砜及亚砜类化合物8个,结构经1H NMR确证。活性初筛发现化合物5c的抑制活性明显强于先导化合物。结论合成方法简单,原料廉价易得。ELISA法测定发现5c的PTK抑制活性较强。 Objective To use Ex-Rad as a lead compound to design and synthesize aryl benzyl sulfones derivatives with protein tyrosine kinases(PTK) inhibitory activity. Methods 2-Naphthol was used as a raw material to synthesize intermediates 3a-3f. The target compounds 4a, 4d, and 5a-5f were synthesized by oxidizing 3a-3f in acetic acid with H2O2. Enzyme-linked immunosorbent assay(ELISA) was used and inhibition rate was calculated to screen out the compounds with PTK inhibitory activitity. Results Eight compounds containing a sulfone or sulfoxide group were synthesized and the structures were confirmed by 1H NMR. Preliminary evaluation of the 8 compounds demonstrated that the PTK inhibitory activity of 5c was much stronger than that of the lead compound. Conclusion The synthetic method is simple, and the materials are cheap and readily available. 5c shows strong PTK inhibitory activity by ELISA.
出处 《国际药学研究杂志》 CAS CSCD 北大核心 2015年第3期351-354,共4页 Journal of International Pharmaceutical Research
基金 国家自然科学基金资助项目(81273431,81072531,30770655,21102176)
关键词 设计合成 芳苄基砜 蛋白酪氨酸激酶抑制剂 design and synthesis aryl benzyl sulfones protein tyrosine kinases inhibitor
  • 相关文献

参考文献12

  • 1Li S, Gerald M. Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhihitors [J]. Drug Discov Today, 2000, 5(8): 344-353.
  • 2Doriano F, David P, Alex M. Protein tyrosine kinase inhibitors:new treatment modalities [J]. Cttrr Opin Pharrrutcol, 2002, 2 (4): 374-381.
  • 3Chun AW, Freshwater RE, Taft DR, et al. Effects of formula- tion and route of administration on the systemic availability of Ex-Rad?, a new radioprotectant, a prectinical species [J]. BiopharmDrugDispos, 2011, 32(2): 99-1ll.
  • 4Kang AD, Cosenza SC, Bonagura M, et al. ON01210.Na (Ex- RAD ) mitigates radiation damage through activation of the AKT pathway [J]. PLoSone, 2013, 8(3): e58355.
  • 5Suman S, Maniar M, Fornace AJ Jr, et cd. Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response[J]. Rcutiat Oncol, 2012, 7:6.
  • 6Yuan ZM, Huang Y, Ishiko T, et al. Regulation of DNA dana- age-induced apoptosis by the c-Abl tyrosine kinase [J]. Proe Natl Acad Sci USA, 1997, 94(4): 1437-1440.
  • 7Bryliakov KP, Talsi EP. Catalytic enantioselective oxidation of bulky aryl thioethers with H202 over titanium-salan catalysts [J]. Eur J Org Chem, 2011, 24: 4693-4698.
  • 8彭涛,颜海燕,温晓雪,张首国,王林.新型辐射保护剂Ex-Rad的合成工艺改进[J].中国新药杂志,2014,23(14):1689-1691. 被引量:4
  • 9Phadnis SP. Interaction of 1- and 2-naphthols with Bunte salts. Formation of related naphthyl benzyl sulfides [J]. lndiart J Chem, 1972, 10(7): 699-702.
  • 10O'Mahony GE, Eccles KS, Morrison RE, et rd. Investigation of steric and electronic effects in the copper-catalysed asym-metric oxidation in suffides[J]. Tetrahedron, 2013, 69(47): 10168- 10184.

二级参考文献15

  • 1许治良,高虹,欧阳克清,郑旭煦,蔡昭皙,胡应和.G-蛋白偶联受体的功能测定和高通量药物筛选[J].中国药理学通报,2003,19(12):1330-1365. 被引量:12
  • 2Venter JC, Adams MD, Myers EW et al. The sequence of the human genome[J]. Science,2001,291(5507): 1304-51.
  • 3Jianying Gu, Xun Gu. Natural history and functional divergence of protein tyrosine kinases[J]. Gene,2003,317(1):49-57.
  • 4Wan YS, Wang ZQ, Voorhees J et al. EGF receptor crosstalks with cytokine receptors leading to the activation of c-jun kinase in response to UV irradiation in human keratinocyte[J]. Cellular signaling, 2001, 13(2):139-44.
  • 5www.chemicon.com/resource/newsltrs/nsl2-2-638.pdf.[OL].
  • 6Weber C, Negrescu E, Erl W et al.Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules[J].J Immunol,1995,155(1):445-51.
  • 7SUMAN S, DATTA K, DOIRON K, et al. Radioprotective effects of ON 01210.Na upon oral administration[J]. J Radiat Res, 2012, 53(3): 368-376.
  • 8CHUN AW, FRESHWATER RE, TAFT DR, et al. Effects of formulation and route of administration on the systemic availability of Ex-RAD, a new radioprotectant, in preclinical species[J]. Biopharm Drug Dispos, 2011, 32(2): 99-11.
  • 9GHOSH SP, PERKINS MW, HIEBER K, et al. Radiation protection by a new chemical entity, Ex-RadTM: efficacy and mechanisms[J]. Radiat Res, 2009, 171(2): 173-179.
  • 10REDDY PE, REDDY MVR, COSENZA SC, et al. Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones: WO, 02069892 [P]. 2002-09-12.

共引文献18

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部